{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:48Z","timestamp":1783075908960,"version":"3.54.6"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1023\/a:1016478708902","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T22:29:52Z","timestamp":1041114592000},"page":"1034-1037","source":"Crossref","is-referenced-by-count":24,"title":["The N-Demethylation of the Doxepin Isomers Is Mainly Catalyzed by the Polymorphic CYP2C19"],"prefix":"10.1007","volume":"19","author":[{"given":"Sebastian","family":"H\u00e4rtter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnel","family":"Tybring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Weigmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"375191_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003495-197713030-00001","volume":"13","author":"R. M. Pinder","year":"1977","unstructured":"R. M. Pinder, R. N. Brogden, T. M. Speight, and G. S. Avery. Doxepin up-to-date; A review of its pharmacological properties and therapeutic efficacy with particular reference to depression. Drugs\n13:161\u2013218 (1977).","journal-title":"Drugs"},{"key":"375191_CR2","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/0006-2952(69)90290-1","volume":"18","author":"D. C. Hobbs","year":"1969","unstructured":"D. C. Hobbs. Distribution and metabolism of doxepin. Biochem. Pharmacol. 18:1942\u20131954 (1969).","journal-title":"Biochem. Pharmacol."},{"key":"375191_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF00314865","volume":"42","author":"K. K. Midha","year":"1992","unstructured":"K. K. Midha, J. W. Hubbard, G. McKay, E. M. Hawes, E. D. Korchinsky, T. Gurnsey, J. K. Cooper, and R. Schwede. Stereoselective pharmacokinetics of doxepin isomers. Eur. J. Clin. Pharmacol. 42:539\u2013544 (1992).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"375191_CR4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/004982597239831","volume":"27","author":"J-H. Yan","year":"1997","unstructured":"J-H. Yan, J. W. Hubbard, G. McKay, and K. K. Midha. Stereoselective in vivo and in vitro studies on the metabolism of doxepin and N-desmethyldoxepin. Xenobiotica\n27:1245\u20131257 (1997).","journal-title":"Xenobiotica"},{"key":"375191_CR5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0090-9556(25)07194-6","volume":"19","author":"H. Ghabrial","year":"1991","unstructured":"H. Ghabrial, C. Prakash, U. G. Tacke, I. A. Blair, and G. R. Wilkinson. Geometric isomerization of doxepin during its N-demethylation in humans. Drug Metab. Dispos. 19:596\u2013600 (1991).","journal-title":"Drug Metab. Dispos."},{"key":"375191_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00008571-200010000-00003","volume":"10","author":"V. S. Haritos","year":"2000","unstructured":"V. S. Haritos, H. Ghabrial, J. T. Ahokas, and M. S. Ching. Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E-and Z-doxepin. Pharmacogenetics\n10:591\u2013603 (2000).","journal-title":"Pharmacogenetics"},{"key":"375191_CR7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0006-2952(93)90272-X","volume":"45","author":"K. Br\u00f8sen","year":"1993","unstructured":"K. Br\u00f8sen, E. Skjelbo, B. B. Rasmussen, H. E. Poulsen, and S. Loft. Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem. Pharmacol. 45:1211\u20131214 (1993).","journal-title":"Biochem. Pharmacol."},{"key":"375191_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/clpt.1991.4","volume":"49","author":"E. Skjelbo","year":"1991","unstructured":"E. Skjelbo, K. Br\u00f8sen, J. Hallas, and L. F. Gram. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine. Clin. Pharmacol. Ther. 49:18\u201323 (1991).","journal-title":"Clin. Pharmacol. Ther."},{"key":"375191_CR9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00008571-199512000-00004","volume":"5","author":"M. Chang","year":"1995","unstructured":"M. Chang, M. L. Dahl, G. Tybring, E. Gotharson, and L. Bertilsson. Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. Pharmacogenetics\n5: 358\u2013363 (1995).","journal-title":"Pharmacogenetics"},{"key":"375191_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1081\/DMR-100101934","volume":"31","author":"T. Friedberg","year":"1999","unstructured":"T. Friedberg, M. P. Pritchard, M. Bandera, S. P. Hanlon, D. Yao, L. A. McLaughlin, S. Ding, B. Burchell, and C. R. Wolf. Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparison. Drug Metab. Rev.\n31:523\u2013544 (1999).","journal-title":"Drug Metab. Rev."},{"key":"375191_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-4347(96)00451-3","volume":"691","author":"J-H. Yan","year":"1997","unstructured":"J-H. Yan, J. W. Hubbard, G. McKay, and K. K. Midha. Stereoselective and simultaneous measurement of cis-and transisomers of doxepin and N-desmethyldoxepin in plasma or urine by high-performance liquid chromatography. J Chromotogr. B Biomed. Appl. 691:131\u2013138 (1997).","journal-title":"J Chromotogr. B Biomed. Appl."},{"key":"375191_CR12","first-page":"14","volume":"60","author":"M. F. Paine","year":"1996","unstructured":"M. F. Paine, D. D. Shen, K. L. Kunze, J. D. Perkins, C. L. Marsh, J. P. Mc Vicar, D. M. Barr, B. S. Gillies, and K. E. Thummel. First-pass metabolism of midazolam by the human intestine. Clin. Pharmacol. Ther. 60:14\u201324 (1996).","journal-title":"Clin. Pharmacol. Ther."},{"key":"375191_CR13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3109\/00498259609050260","volume":"26","author":"S. Ono","year":"1996","unstructured":"S. Ono, T. Hatanaka, S. Miyazawa, M. Tsutsui, T. Aoyama, F. J. Gonzalez, and T. Satoh. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s; role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica\n26:1155\u20131166 (1996).","journal-title":"Xenobiotica"},{"key":"375191_CR14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","volume":"270","author":"T. Shimada","year":"1994","unstructured":"T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F. P. Guengerich. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals; studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:414\u2013423 (1994).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"375191_CR15","first-page":"897","volume":"29","author":"W. Zhang","year":"2001","unstructured":"W. Zhang, T. Kilicarslan, R. F. Tyndale, and E. M. Sellers. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab. Dispos.\n29:897\u2013902 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"375191_CR16","first-page":"1110","volume":"29","author":"M. Nakajima","year":"2001","unstructured":"M. Nakajima, R. Yoshida, N. Shimada, H. Yamazaki, and T. Yokoi. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab. Dispos. 29: 1110\u20131113 (2001).","journal-title":"Drug Metab. Dispos."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016478708902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1016478708902\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016478708902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:56:37Z","timestamp":1754038597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1016478708902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["375191"],"URL":"https:\/\/doi.org\/10.1023\/a:1016478708902","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}